ArticleBMC public health2025
Impact of the Triglyceride-Glucose index on all-cause and cardiovascular mortalities across different metabolic health and obesity statuses in US adults.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- The prognostic value of combined TyG and SIRI categories for cardiovascular disease and all-cause mortality among adults: Evidence from the NHANES 1999-2010.American heart journal plus : cardiology research and practice · 2026Article
- Joint association of triglyceride-glucose index and Chinese visceral adiposity index with prevalent diabetes: a cross-sectional study.Frontiers in endocrinology · 2026Article
- The association between triglyceride-glucose index and all-cause/cardiovascular mortality in patients with different glucose metabolism statuses.Cardiovascular diabetology · 2025Article
- Triglyceride glucose-weight-adjusted waist index as a cardiovascular mortality predictor: incremental value beyond the establishment of TyG-related indices.Cardiovascular diabetology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundData for the study cohort were sourced from the National Health and Nutrition Examination Survey (1999-2018). Study participants were classified as obese (BMI ≥ 30 kg/m²) or nonobese (BMI < 30 kg/m²) then further categorized as metabolically healthy or unhealthy on the basis of metabolic syndrome criteria, resulting in four groups: metabolically healthy obese (MHO), metabolically unhealthy obese (MUO), metabolically healthy nonobese (MHNO), and metabolically unhealthy nonobese (MUNO). Complex sampling statistical methods were employed for descriptive analysis. The associations between the TyG index and mortality, including all-cause and cardiovascular mortalities, were examined by using multivariable Cox regression and restricted cubic splines (RCS). The reliability of the results was confirmed through multiple sensitivity analyses.
methodsData for the study cohort were sourced from the National Health and Nutrition Examination Survey (1999-2018). Study participants were classified as obese (BMI ≥ 30 kg/m²) or nonobese (BMI < 30 kg/m²) then further categorized as metabolically healthy or unhealthy on the basis of metabolic syndrome criteria, resulting in four groups: metabolically healthy obese (MHO), metabolically unhealthy obese (MUO), metabolically healthy nonobese (MHNO), and metabolically unhealthy nonobese (MUNO). Complex sampling statistical methods were employed for descriptive analysis. The associations between the TyG index and mortality, including all-cause and cardiovascular mortalities, were examined by using multivariable Cox regression and restricted cubic splines (RCS). The reliability of the results was confirmed through multiple sensitivity analyses.
resultsA total of 16 179 participants were included, with a median follow-up of 129 months. Over this follow-up period, 1875 participants (11.59%) died from all causes, including 568 (3.51%) who died due to cardiovascular diseases. After adjustment for confounding variables, the TyG index significantly predicted mortality in the overall and metabolically unhealthy populations: for each one standard deviation increase in the TyG index, all-cause mortality increased by 1.42 times (95% confidence interval [CI]: 1.27, 1.58) in the overall population, by 1.62 times (95% CI: 1.36, 1.93) in the MUNO group, and by 1.47 times (95% CI: 1.26, 1.71) in the MUO group. Cardiovascular mortality in the overall population increased by 1.52 times (95% CI: 1.27, 1.82), that in the MUNO group increased by 2.01 times (95% CI: 1.49, 2.72), and that in the MUO group increased by 1.47 times (95% CI: 1.14, 1.88). No significant association was found in the metabolically healthy populations regardless of obesity status. RCS and sensitivity analyses further confirmed and visualized these conclusions.
conclusionsThe TyG index is positively correlated with mortality risk in the overall and metabolically unhealthy populations but not in the metabolically healthy populations. This finding indicates that the predictive value of the TyG index for mortality differs across populations, highlighting the necessity of accounting for metabolic status when the TyG index is used for prognostic evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.